Showing results (331-340 of 679) with videos related to
Sort By:
Pageof 68
Advances in Therapy|February 21, 2020
Split First Dose Administration of Intravenous Daratumumab for the Treatment of Multiple Myeloma (MM): Clinical and Population Pharmacokinetic AnalysesXu Steven Xu, Philippe Moreau, Saad Z Usmani, et al.Bone Marrow Transplantation|May 16, 2019
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndromeThierry Guillaume, Florent Malard, Leonardo Magro, et al.Haematologica|August 24, 2019
Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma NetworkPhilippe Moreau, Pieter Sonneveld, Mario Boccadoro, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 TrialsJean-Luc Harousseau, Herve Avet-Loiseau, Michel Attal, et al.Ejhaem|March 22, 2022
Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplantMaxime Jullien, Marianne Coste-Burel, Beatrice Clemenceau, et al.Bulletin Du Cancer|December 18, 2021
[DESCAR-T, a nationwide registry for patient treated by CAR-T Cells in France]Florence Broussais, Jacques Olivier Bay, Nicolas Boissel, et al.Haematologica|August 27, 2016
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemiaMohamad Mohty, Florent Malard, Didier Blaise, et al.Blood|March 19, 2015
Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myelomaPhilippe Moreau, Brigitte Kolb, Michel Attal, et al.The Journal of Rheumatology|April 17, 2009
HLA-G expression in the skin of patients with systemic sclerosisIsabela J Wastowski, Percival D Sampaio-Barros, Eliane M I Amstalden, et al.Clinical Lymphoma, Myeloma & Leukemia|July 21, 2023
Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup AnalysisYawara Kawano, Kihyun Kim, Chang Ki Min, et al.Pageof 68